WST icon

West Pharmaceutical

220.16 USD
-3.72
1.66%
At close Apr 1, 4:00 PM EDT
After hours
220.16
+0.00
0.00%
1 day
-1.66%
5 days
-2.63%
1 month
-3.46%
3 months
-32.96%
6 months
-26.56%
Year to date
-32.96%
1 year
-44.40%
5 years
46.97%
10 years
286.99%
0
Funds holding %
of 7,398 funds
0
Analysts bullish %
of 3 analysts

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

150% more funds holding in top 10

Funds holding in top 10: 4 [Q3] → 10 (+6) [Q4]

26% more first-time investments, than exits

New positions opened: 101 | Existing positions closed: 80

12% more repeat investments, than reductions

Existing positions increased: 286 | Existing positions reduced: 256

11% more capital invested

Capital invested by funds: $20.5B [Q3] → $22.8B (+$2.27B) [Q4]

1.33% more ownership

Funds ownership: 94.64% [Q3] → 95.98% (+1.33%) [Q4]

1% more funds holding

Funds holding: 720 [Q3] → 728 (+8) [Q4]

44% less call options, than puts

Call options by funds: $77.4M | Put options by funds: $139M

Research analyst outlook

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$275
25%
upside
Avg. target
$333
51%
upside
High target
$400
82%
upside

3 analyst ratings

positive
100%
neutral
0%
negative
0%
Evercore ISI Group
Daniel Markowitz
0% 1-year accuracy
0 / 2 met price target
25%upside
$275
Outperform
Initiated
18 Mar 2025
Keybanc
Paul Knight
22% 1-year accuracy
2 / 9 met price target
48%upside
$325
Overweight
Maintained
14 Feb 2025
Citigroup
Thomas Palmer
25% 1-year accuracy
8 / 32 met price target
82%upside
$400
Buy
Initiated
8 Jan 2025

Financial journalist opinion

Based on 23 articles about WST published over the past 30 days

Neutral
Accesswire
8 hours ago
Shareholders that Lost Money on West Pharmaceutical Services, Inc. (WST) Should Contact Levi & Korsinsky About Securities Fraud Investigation - WST
NEW YORK, NY / ACCESS Newswire / April 1, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.
Shareholders that Lost Money on West Pharmaceutical Services, Inc. (WST) Should Contact Levi & Korsinsky About Securities Fraud Investigation - WST
Positive
Seeking Alpha
1 day ago
Best Dividend Aristocrats For April 2025
Dividend Aristocrats are outperforming the S&P 500 in 2025, demonstrating resilience, with NOBL up 1.78% YTD versus SPY's 4.9% decline. Top performers include Consolidated Edison (+22.98%), Brown & Brown (+20.65%), and AbbVie (+16.61%), showcasing strong double-digit gains. 29 out of 69 Dividend Aristocrats have announced dividend increases in 2025, with an average growth rate of 4.15%.
Best Dividend Aristocrats For April 2025
Neutral
Accesswire
1 day ago
WST ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your West Pharmaceutical Services, Inc. investment
NEW YORK, NY / ACCESS Newswire / March 31, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.
WST ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your West Pharmaceutical Services, Inc. investment
Neutral
Accesswire
4 days ago
West Pharmaceutical Services, Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details - WST
NEW YORK, NY / ACCESS Newswire / March 28, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.
West Pharmaceutical Services, Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details - WST
Neutral
Accesswire
5 days ago
WST ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your West Pharmaceutical Services, Inc. investment
NEW YORK, NY / ACCESS Newswire / March 27, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.
WST ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your West Pharmaceutical Services, Inc. investment
Neutral
Accesswire
6 days ago
West Pharmaceutical Services, Inc. (WST) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights
NEW YORK, NY / ACCESS Newswire / March 26, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.
West Pharmaceutical Services, Inc. (WST) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights
Neutral
Accesswire
1 week ago
West Pharmaceutical Services, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - WST
NEW YORK, NY / ACCESS Newswire / March 25, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.
West Pharmaceutical Services, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - WST
Neutral
Accesswire
1 week ago
Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. Investors of the Ongoing Investigation into Potential Violations of Securities Laws - WST
NEW YORK, NY / ACCESS Newswire / March 24, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.
Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. Investors of the Ongoing Investigation into Potential Violations of Securities Laws - WST
Neutral
Accesswire
1 week ago
Levi & Korsinsky Reminds Shareholders of an Investigation into West Pharmaceutical Services, Inc. (WST) Regarding Potential Securities Fraud Allegations
NEW YORK, NY / ACCESS Newswire / March 21, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.
Levi & Korsinsky Reminds Shareholders of an Investigation into West Pharmaceutical Services, Inc. (WST) Regarding Potential Securities Fraud Allegations
Neutral
Accesswire
1 week ago
West Pharmaceutical Services, Inc. Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - WST
NEW YORK, NY / ACCESS Newswire / March 20, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.
West Pharmaceutical Services, Inc. Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - WST
Charts implemented using Lightweight Charts™